These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 38296539

  • 1. Biofilm Eradication of Stenotrophomonas maltophilia by Levofloxacin and Trimethoprim-Sulfamethoxazole.
    Río-Chacón JMD, Rojas-Larios F, Bocanegra-Ibarias P, Salas-Treviño D, Espinoza-Gómez F, Camacho-Ortiz A, Flores-Treviño S.
    Jpn J Infect Dis; 2024 Jul 23; 77(4):213-219. PubMed ID: 38296539
    [Abstract] [Full Text] [Related]

  • 2. Drug Resistance in Biofilm and Planktonic Cells of Achromobacter spp., Burkholderia spp., and Stenotrophomonas maltophilia Clinical Isolates.
    Montoya-Hinojosa EI, Villarreal-Treviño L, Bocanegra-Ibarias P, Camacho-Ortiz A, Flores-Treviño S.
    Microb Drug Resist; 2024 Sep 23; 30(9):354-362. PubMed ID: 39029506
    [Abstract] [Full Text] [Related]

  • 3. Effect of antimicrobials on Stenotrophomonas maltophilia biofilm.
    Santos Carvalhais BE, Souza E Silva C, Dos Santos KV.
    Future Microbiol; 2021 Jan 23; 16(2):83-93. PubMed ID: 33470844
    [Abstract] [Full Text] [Related]

  • 4. Temperature, pH and Trimethoprim-Sulfamethoxazole Are Potent Inhibitors of Biofilm Formation by Stenotrophomonas maltophilia Clinical Isolates.
    Biočanin M, Madi H, Vasiljević Z, Kojić M, Jovčić B, Lozo J.
    Pol J Microbiol; 2017 Dec 04; 66(4):433-438. PubMed ID: 29319523
    [Abstract] [Full Text] [Related]

  • 5. Stenotrophomonas maltophilia in Mexico: antimicrobial resistance, biofilm formation and clonal diversity.
    Flores-Treviño S, Gutiérrez-Ferman JL, Morfín-Otero R, Rodríguez-Noriega E, Estrada-Rivadeneyra D, Rivas-Morales C, Llaca-Díaz JM, Camacho-Ortíz A, Mendoza-Olazarán S, Garza-González E.
    J Med Microbiol; 2014 Nov 04; 63(Pt 11):1524-1530. PubMed ID: 25165124
    [Abstract] [Full Text] [Related]

  • 6. Activity of Potential Alternative Treatment Agents for Stenotrophomonas maltophilia Isolates Nonsusceptible to Levofloxacin and/or Trimethoprim-Sulfamethoxazole.
    Biagi M, Tan X, Wu T, Jurkovic M, Vialichka A, Meyer K, Mendes RE, Wenzler E.
    J Clin Microbiol; 2020 Jan 28; 58(2):. PubMed ID: 31748318
    [Abstract] [Full Text] [Related]

  • 7. Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital.
    Duan Z, Qin J, Liu Y, Li C, Ying C.
    BMC Microbiol; 2020 Sep 29; 20(1):294. PubMed ID: 32993493
    [Abstract] [Full Text] [Related]

  • 8. Risk factors and molecular mechanisms associated with trimethoprim-sulfamethoxazole resistance in Stenotrophomonas maltophilia in Mexico.
    Herrera-Heredia SA, Pezina-Cantú C, Garza-González E, Bocanegra-Ibarias P, Mendoza-Olazarán S, Morfín-Otero R, Camacho-Ortiz A, Villarreal-Treviño L, Rodríguez-Noriega E, Paláu-Davila L, Maldonado-Garza HJ, Flores-Treviño S.
    J Med Microbiol; 2017 Aug 29; 66(8):1102-1109. PubMed ID: 28771141
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibility of hospital acquired Stenotrophomonas maltophilia isolate biofilms.
    Sun E, Liang G, Wang L, Wei W, Lei M, Song S, Han R, Wang Y, Qi W.
    Braz J Infect Dis; 2016 Aug 29; 20(4):365-73. PubMed ID: 27183359
    [Abstract] [Full Text] [Related]

  • 10. Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients.
    Wang CH, Yu CM, Hsu ST, Wu RX.
    J Hosp Infect; 2020 Jan 29; 104(1):46-52. PubMed ID: 31505224
    [Abstract] [Full Text] [Related]

  • 11. Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole on Achromobacter, Burkholderia, and Stenotrophomonas isolates.
    Montoya-Hinojosa EI, Salazar-Sesatty HA, Alvizo-Baez CA, Terrazas-Armendariz LD, Luna-Cruz IE, Alcocer-González JM, Villarreal-Treviño L, Flores-Treviño S.
    Expert Rev Anti Infect Ther; 2023 Feb 29; 21(2):213-223. PubMed ID: 36625029
    [Abstract] [Full Text] [Related]

  • 12. Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.
    Nys C, Cherabuddi K, Venugopalan V, Klinker KP.
    Antimicrob Agents Chemother; 2019 Nov 29; 63(11):. PubMed ID: 31427300
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates.
    Bostanghadiri N, Ardebili A, Ghalavand Z, Teymouri S, Mirzarazi M, Goudarzi M, Ghasemi E, Hashemi A.
    BMC Res Notes; 2021 Apr 20; 14(1):151. PubMed ID: 33879237
    [Abstract] [Full Text] [Related]

  • 14. Isolation and Characterization of Stenotrophomonas maltophilia Isolates from a Brazilian Hospital.
    Gallo SW, Figueiredo TP, Bessa MC, Pagnussatti VE, Ferreira CA, Oliveira SD.
    Microb Drug Resist; 2016 Dec 20; 22(8):688-695. PubMed ID: 27007167
    [Abstract] [Full Text] [Related]

  • 15. Biofilm compared to conventional antimicrobial susceptibility of Stenotrophomonas maltophilia Isolates from cystic fibrosis patients.
    Wu K, Yau YC, Matukas L, Waters V.
    Antimicrob Agents Chemother; 2013 Mar 20; 57(3):1546-8. PubMed ID: 23295930
    [Abstract] [Full Text] [Related]

  • 16. Emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole-resistant Stenotrophomonas maltophilia: Risk factors and antimicrobial sensitivity pattern analysis from a single medical center in Taiwan.
    Wu RX, Yu CM, Hsu ST, Wang CH.
    J Microbiol Immunol Infect; 2022 Feb 20; 55(1):107-113. PubMed ID: 33500210
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic susceptibility of sulfamethoxazole-trimethoprim resistant Stenotrophomonas maltophilia strains isolated at a tertiary care centre in Hungary.
    Juhász E, Pongrácz J, Iván M, Kristóf K.
    Acta Microbiol Immunol Hung; 2015 Sep 20; 62(3):295-305. PubMed ID: 26551572
    [Abstract] [Full Text] [Related]

  • 18. Levofloxacin Efflux and smeD in Clinical Isolates of Stenotrophomonas maltophilia.
    Chong SY, Lee K, Chung HS, Hong SG, Suh Y, Chong Y.
    Microb Drug Resist; 2017 Mar 20; 23(2):163-168. PubMed ID: 27294684
    [Abstract] [Full Text] [Related]

  • 19. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens.
    Çıkman A, Parlak M, Bayram Y, Güdücüoğlu H, Berktaş M.
    Afr Health Sci; 2016 Mar 20; 16(1):149-52. PubMed ID: 27358626
    [Abstract] [Full Text] [Related]

  • 20. Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia.
    Biagi M, Vialichka A, Jurkovic M, Wu T, Shajee A, Lee M, Patel S, Mendes RE, Wenzler E.
    Antimicrob Agents Chemother; 2020 Aug 20; 64(9):. PubMed ID: 32571820
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.